Silexion Therapeutics Corp (SLXN)
NASDAQ: SLXN · Real-Time Price · USD
0.3601
-0.0001 (-0.03%)
Aug 28, 2026, 1:42 PM EDT - Market open
Silexion Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2013 | FY 2012 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '13 Dec 31, 2013 | Dec '12 Dec 31, 2012 |
Cash & Equivalents | 2.23 | 5.99 | 1.19 | 4.6 | 0.79 | 1.6 |
Cash & Short-Term Investments | 2.23 | 5.99 | 1.19 | 4.6 | 0.79 | 1.6 |
Cash Growth | - | 404.72% | -74.17% | 483.12% | -50.69% | - |
Other Receivables | - | - | - | - | 0.09 | 0.16 |
Receivables | - | - | - | - | 0.09 | 0.16 |
Prepaid Expenses | 1.37 | 0.57 | 0.97 | 0.34 | 0.01 | - |
Restricted Cash | 0.03 | 0.03 | 0.04 | 0.03 | - | - |
Other Current Assets | 0.11 | 0.05 | 0.06 | 0.02 | 0.04 | 0.03 |
Total Current Assets | 3.74 | 6.64 | 2.25 | 4.98 | 0.93 | 1.79 |
Property, Plant & Equipment | 0.37 | 0.44 | 0.56 | 0.25 | 0.01 | 0.01 |
Other Long-Term Assets | 0.14 | 0.14 | 0.05 | 0.03 | - | - |
Total Assets | 4.25 | 7.22 | 2.86 | 5.26 | 0.94 | 1.8 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2013 | FY 2012 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '13 Dec 31, 2013 | Dec '12 Dec 31, 2012 |
Accounts Payable | 1.18 | 0.79 | 0.93 | 0.32 | 0.1 | 0.08 |
Accrued Expenses | 1.56 | 1.74 | 1.38 | 1.57 | 0.14 | 0.09 |
Short-Term Debt | 0.99 | - | 1 | - | - | - |
Current Portion of Leases | 0.2 | 0.18 | 0.16 | 0.11 | - | - |
Current Income Taxes Payable | 0.05 | 0.05 | 0.05 | - | - | - |
Other Current Liabilities | - | - | 0 | 0.2 | - | - |
Total Current Liabilities | 3.98 | 2.76 | 3.52 | 2.2 | 0.24 | 0.17 |
Long-Term Debt | - | 1.57 | 2.96 | - | - | - |
Long-Term Leases | 0.23 | 0.29 | 0.37 | 0.06 | - | - |
Total Liabilities | 4.2 | 4.61 | 6.85 | 2.26 | 0.24 | 0.17 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2013 | FY 2012 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '13 Dec 31, 2013 | Dec '12 Dec 31, 2012 |
Common Stock | 0.16 | 0.04 | 0 | - | - | - |
Additional Paid-In Capital | 61.33 | 57.73 | 39.26 | 11.34 | 5.16 | 4.74 |
Retained Earnings | -61.45 | -55.17 | -43.25 | -26.81 | -4.47 | -3.11 |
Total Common Equity | 0.04 | 2.6 | -3.99 | -15.48 | 0.7 | 1.63 |
Minority Interest | - | - | - | 3.42 | - | - |
Shareholders' Equity | 0.04 | 2.6 | -3.99 | 3 | 0.7 | 1.63 |
Total Liabilities & Equity | 4.25 | 7.22 | 2.86 | 5.26 | 0.94 | 1.8 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2013 | FY 2012 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '13 Dec 31, 2013 | Dec '12 Dec 31, 2012 |
Total Debt | 1.41 | 2.04 | 4.49 | 0.17 | - | - |
Net Cash (Debt) | 0.82 | 3.96 | -3.3 | 4.42 | 0.79 | 1.6 |
Net Cash Growth | - | - | - | 461.42% | -50.69% | - |
Net Cash Per Share | 2.27 | 29.75 | - | - | - | - |
Filing Date Shares Outstanding | 5.56 | 0.33 | 0.06 | - | - | - |
Total Common Shares Outstanding | 5.56 | 0.31 | 0.01 | - | - | - |
Working Capital | -0.24 | 3.88 | -1.27 | 2.78 | 0.69 | 1.62 |
Book Value Per Share | 0.01 | 8.33 | -323.65 | - | - | - |
Tangible Book Value | 0.04 | 2.6 | -3.99 | -15.48 | 0.7 | 1.63 |
Tangible Book Value Per Share | 0.01 | 8.33 | -323.65 | - | - | - |
Machinery | - | 0.11 | 0.1 | 0.08 | 0.02 | 0.01 |
Leasehold Improvements | - | - | - | 0.06 | - | - |